Cannabis Drug Testing Laws in Rhode Island
Rhode Island § 21-28.11-29 protects private lawful off-duty cannabis use. Metabolites alone do not establish impairment. Random drug testing was already prohibited.
Overview
Rhode Island legalized recreational cannabis in 2022. R.I. Gen. Laws § 21-28.11-29 specifically prohibits adverse employment action for private, lawful off-duty cannabis use. § 28-6.5-1 has long prohibited random drug testing by most private employers.
| State | Rhode Island (RI) |
| Legal Status | Recreational Legal |
| Workplace Protection | Strong Protections |
| Protection Summary | Strong. Cannabis metabolites alone cannot establish impairment. Random drug testing was already largely prohibited under pre-existing law. |
| Safety-Sensitive Exemption | Federal contractor exception and limited safety-sensitive carve-outs. |
| DUI Threshold | Impairment-based DUI. |
| Synthetic Urine Law | Not specifically criminalized. |
Key Statutes
- R.I. Gen. Laws § 21-28.11-29 (Cannabis Act)
- R.I. Gen. Laws § 28-6.5-1 (Drug testing limitations)
Key Court Cases
- Callaghan v. Darlington Fabrics (R.I. Super. 2017) — Hawkins-Slater Act protects medical cannabis cardholder hiring. Implied private right of action. This was the first state court decision in the country finding such protections.
Practical Notes
Rhode Island Cannabis Context
Rhode Island legalized recreational cannabis in 2022 (the Rhode Island Cannabis Act). The state's cannabis worker protection framework is unusually strong because it combines pre-existing drug testing limitations with new cannabis-specific protections. R.I. Gen. Laws § 28-6.5-1 has long prohibited most random drug testing by private employers in Rhode Island — one of the strongest pre-existing testing limitations in the country. The new R.I. Gen. Laws § 21-28.11-29 adds specific cannabis off-duty use protections and explicitly states that metabolites alone do not establish impairment.
The Callaghan v. Darlington Fabrics decision (R.I. Super. 2017) was the first state court decision in the country to find an implied private right of action under a medical cannabis employment protection statute. Christine Callaghan was a college intern denied placement at Darlington Fabrics after disclosing her medical cannabis card. The Rhode Island Superior Court ruled that the Hawkins-Slater Act's protection of "status as cardholder" includes actual medical cannabis use, opening the door for similar litigation in multiple other states.
Rhode Island's economy includes significant healthcare (Lifespan, Care New England), education (Brown University, multiple other institutions), tourism, and Naval Station Newport (federal employment). The state has not enacted broad synthetic urine criminalization. Rhode Island uses impairment-based DUI rather than zero-tolerance per se. For Rhode Island workers, the combination of the long-standing random testing ban, the Cannabis Act protections, the Hawkins-Slater Act with Callaghan precedent, and the metabolites-alone limitation creates one of the most worker-protective cannabis testing environments in the country. The federal contractor exception applies as everywhere, but for non-federal private sector positions in Rhode Island, the protections are genuinely strong.
What This Means for You
Rhode Island is one of the strong-protection states. Private employers in most positions cannot take adverse action against you based on off-duty cannabis use or a positive test for nonpsychoactive metabolites alone. However:
- Federal contractor and DOT positions remain subject to federal rules — see Federal Rules
- Safety-sensitive positions typically fall outside the state protection — see Safety-Sensitive Positions
- Impairment at work is never protected, regardless of the state statute
- Federal employment and security clearances remain off-limits for cannabis users